Daniel L. Mosley
About Daniel L. Mosley
Independent director since 2023 (age 68) with a legal and financial background; currently Partner and Head of Family Advisory Services at BDT & MSD Partners and formerly a Partner at Cravath, Swaine & Moore LLP. His WRB board term expires in 2026, and he is designated independent; core credentials include substantial legal and financial expertise and nonprofit board leadership.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| BDT & MSD Partners | Partner and Head of Family Advisory Services | Since Jan 2023 | Advises families; brings financial/legal insights to WRB board |
| BDT & Company | Partner | 2018–2022 | Family advisory; financial expertise |
| Cravath, Swaine & Moore LLP | Partner | 1987–June 2018 | Deep legal expertise |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Pinkerton Foundation | Chairman of the Board | Not disclosed (current) | Nonprofit governance |
| Greenwich Hospital | Former Chairman of the Board | Not disclosed | Healthcare governance |
| Paley Center; Madison Square Boys & Girls Club; William S. Paley Foundation; Edward John Noble Foundation; Thomas J. Watson Foundation; William E. Simon Foundation | Board member | Not disclosed | Multiple nonprofit boards |
Board Governance
- Committee assignments: Compensation Committee member; Nominating & Corporate Governance Committee member; not a chair.
- Independence: Board currently 10 directors, 8 independent; Mosley is independent.
- Attendance: Board held 4 meetings in 2024; all directors attended 100% of board meetings; most (8) attended 100% of committee meetings (one at 92%, one at 88%).
- Lead independent director/executive sessions: Independent director executive sessions are held regularly, at least annually; presiding director rotates among committee chairs and certain non-management members, effectively creating co-lead independent director responsibilities.
- Compensation governance: Compensation Committee (Farrell—Chair, Blaylock, Mosley) met 5 times in 2024; retained Meridian as independent consultant; committee independence affirmed (no conflicts).
- Say-on-pay support: 2024 say-on-pay approved with 96.1% of votes cast, reflecting positive investor feedback.
Fixed Compensation
| Component | 2024 Value | Details |
|---|---|---|
| Annual Stipend (cash) | $96,000 | Paid quarterly ($24,000) |
| Committee Member Stipend | $5,500 | Applies to Audit and Compensation Committee members; Mosley on Compensation |
| Committee Chair Fee | $0 | $38,500 applies to Audit/Comp chairs; Mosley is not a chair |
| Meeting Fees | Included in fees | $2,000 per board meeting; $1,500 per substantive Audit/Comp meeting |
| Total Fees Earned (cash) | $117,000 | 2024 actual cash fees |
| Deferred Compensation (Director plan) | Available | Directors may defer retainer/meeting fees into the plan |
Performance Compensation
- Equity compensation structure: Directors receive an annual equity grant in common shares valued at $200,000 on the Annual Meeting date; shares must be held until the director leaves the Board (no options; no performance vesting).
- 2024 grant detail (Daniel L. Mosley): 3,801 shares granted on June 11, 2024; grant-date fair value $200,067.
| Equity Award Feature | 2024 | Notes |
|---|---|---|
| Grant date | June 11, 2024 | Annual Meeting grant |
| Shares granted | 3,801 | Common stock |
| Grant-date fair value | $200,067 | $52.635 per share |
| Vesting/Performance | Not performance-based | Full grant; retention requirement |
| Retention requirement | Hold until no longer serving on Board | Alignment mechanism |
WRB director compensation emphasizes equity ownership and retention rather than performance-conditioned awards, aligning director incentives with long-term shareholder value.
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None |
| Compensation committee interlocks | None; committee members (Farrell, Blaylock, Mosley) were not WRB officers and had no related-party relationships requiring disclosure; no cross-committee executive overlaps. |
Expertise & Qualifications
- Substantial legal and financial background; decades as partner at Cravath; senior family advisory roles in financial services.
- Board skill matrix: Finance & reporting, risk assessment & management, governance/regulatory/public policy, ESG management—skills represented among directors including Mosley.
- Nonprofit leadership: Multiple board roles; chairmanships indicate governance depth.
Equity Ownership
| Holder | Shares Beneficially Owned | % of Class |
|---|---|---|
| Daniel L. Mosley | 9,019 | <1% |
- Director stock ownership policy: Within four years of becoming a director, required to own shares equal to five times annual stipend ($480,000); annual equity grant shares must be held until board service ends.
- Anti-hedging/pledging: Officers, directors, and employees are prohibited from hedging WRB stock; shares counted toward ownership guidelines may not be pledged.
Governance Assessment
-
Board effectiveness: Mosley’s legal/financial expertise complements WRB’s committee structure (Compensation; Nominating & Corporate Governance), supporting pay and governance oversight; committee independence and use of an independent consultant strengthen investor confidence.
-
Alignment: Director equity grants retained until service ends and ownership guidelines drive skin-in-the-game; Mosley holds common shares and has no options—consistent with WRB’s alignment approach.
-
Engagement: Full board attendance in 2024 and robust director onboarding/education and rotating presiding director model indicate active, independent oversight.
-
Conflicts/related-party exposure: No related-party transactions disclosed involving Mosley; Compensation Committee interlocks absent.
-
Shareholder signals: Strong say-on-pay approval (96.1%) and governance practices (majority-independent board, separate Chair/CEO, executive sessions) support confidence.
-
RED FLAGS
- None observed specific to Daniel L. Mosley: no disclosed related-party transactions, no director interlocks, no pledging/hedging, and no performance-conditioned director equity that could distort incentives.